Drugs / DFA-02
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/21 trial | ||||||
| Phase 1/2 | NCT01496352 | Feb 2012 → Apr 2013 | — | Dr. Reddy's Laboratories Limited | Completed | No outcome recorded |
| Phase 21 trial | ||||||
| Phase 2 | NCT01888367 | Oct 2013 → Feb 2015 | — | Dr. Reddy's Laboratories Limited | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | DFA-02 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01496352 ↗ |
| Route | Topical | “to be applied during surgical incision closure” NCT01496352 ↗ |